Cargando…
Thalassemia and Hemoglobin E in Southern Thai Blood Donors
Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094851/ https://www.ncbi.nlm.nih.gov/pubmed/25050123 http://dx.doi.org/10.1155/2014/932306 |
_version_ | 1782325906586468352 |
---|---|
author | Nuinoon, Manit Kruachan, Kwanta Sengking, Warachaya Horpet, Dararat Sungyuan, Ubol |
author_facet | Nuinoon, Manit Kruachan, Kwanta Sengking, Warachaya Horpet, Dararat Sungyuan, Ubol |
author_sort | Nuinoon, Manit |
collection | PubMed |
description | Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining the frequency of α-thalassemia 1 trait, β-thalassemia trait, and Hb E-related syndromes in Southern Thai blood donors. One hundred and sixteen voluntary blood donors, Southern Thailand origin, were recruited for thalassemia and Hb E screening by red blood cell indices/dichlorophenolindophenol precipitation test. β-Thalassemia and Hb E were then identified by high performance liquid chromatography and 4 common α-thalassemia deletions were characterized by a single tube-multiplex gap-polymerase chain reaction. Overall frequency of hemoglobinopathies was 12.9%, classified as follows: homozygous α-thalassemia 2 (1.7%), heterozygous α-thalassemia 1 (1.7%), heterozygous β-thalassemia without α-thalassemia (0.9%), heterozygous Hb E without α-thalassemia (5.2%), double heterozygotes for Hb E/α-thalassemia 1 (1.7%), homozygous Hb E without α-thalassemia (0.9%), and homozygous Hb E with heterozygous α-thalassemia 2 (0.9%). The usefulness of thalassemia screening is not only for receiving highly effective red blood cells in the recipients but also for encouraging the control and prevention program of thalassemia in blood donors. |
format | Online Article Text |
id | pubmed-4094851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40948512014-07-21 Thalassemia and Hemoglobin E in Southern Thai Blood Donors Nuinoon, Manit Kruachan, Kwanta Sengking, Warachaya Horpet, Dararat Sungyuan, Ubol Adv Hematol Research Article Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining the frequency of α-thalassemia 1 trait, β-thalassemia trait, and Hb E-related syndromes in Southern Thai blood donors. One hundred and sixteen voluntary blood donors, Southern Thailand origin, were recruited for thalassemia and Hb E screening by red blood cell indices/dichlorophenolindophenol precipitation test. β-Thalassemia and Hb E were then identified by high performance liquid chromatography and 4 common α-thalassemia deletions were characterized by a single tube-multiplex gap-polymerase chain reaction. Overall frequency of hemoglobinopathies was 12.9%, classified as follows: homozygous α-thalassemia 2 (1.7%), heterozygous α-thalassemia 1 (1.7%), heterozygous β-thalassemia without α-thalassemia (0.9%), heterozygous Hb E without α-thalassemia (5.2%), double heterozygotes for Hb E/α-thalassemia 1 (1.7%), homozygous Hb E without α-thalassemia (0.9%), and homozygous Hb E with heterozygous α-thalassemia 2 (0.9%). The usefulness of thalassemia screening is not only for receiving highly effective red blood cells in the recipients but also for encouraging the control and prevention program of thalassemia in blood donors. Hindawi Publishing Corporation 2014 2014-06-23 /pmc/articles/PMC4094851/ /pubmed/25050123 http://dx.doi.org/10.1155/2014/932306 Text en Copyright © 2014 Manit Nuinoon et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nuinoon, Manit Kruachan, Kwanta Sengking, Warachaya Horpet, Dararat Sungyuan, Ubol Thalassemia and Hemoglobin E in Southern Thai Blood Donors |
title | Thalassemia and Hemoglobin E in Southern Thai Blood Donors |
title_full | Thalassemia and Hemoglobin E in Southern Thai Blood Donors |
title_fullStr | Thalassemia and Hemoglobin E in Southern Thai Blood Donors |
title_full_unstemmed | Thalassemia and Hemoglobin E in Southern Thai Blood Donors |
title_short | Thalassemia and Hemoglobin E in Southern Thai Blood Donors |
title_sort | thalassemia and hemoglobin e in southern thai blood donors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094851/ https://www.ncbi.nlm.nih.gov/pubmed/25050123 http://dx.doi.org/10.1155/2014/932306 |
work_keys_str_mv | AT nuinoonmanit thalassemiaandhemoglobineinsouthernthaiblooddonors AT kruachankwanta thalassemiaandhemoglobineinsouthernthaiblooddonors AT sengkingwarachaya thalassemiaandhemoglobineinsouthernthaiblooddonors AT horpetdararat thalassemiaandhemoglobineinsouthernthaiblooddonors AT sungyuanubol thalassemiaandhemoglobineinsouthernthaiblooddonors |